Evidence map›Paper›PMID 26784179›Full record

ReviewInternational journal of molecular sciences2016

Retinal Cell Degeneration in Animal Models.

Masayuki Niwa, Hitomi Aoki, Akihiro Hirata, Hiroyuki Tomita, Paul G Green, Akira Hara

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Differential susceptibility of retinal ganglion cell subtypes against neurodegenerative diseases.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2022
    Review
  15. Article
  16. Stimulation of C-KitFrontiers in pharmacology · 2022
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Masayuki NiwaMedical Science Division, United Graduate School of Drug Discovery and Medical Information Sciences, Gifu 501-1194, Japan. mniwa@gifu-u.ac.jp.
Hitomi AokiDepartment of Tissue and Organ Development, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. hito7ao@gifu-u.ac.jp.
Akihiro HirataDivision of Animal Experiment, Life Science Research Center, Gifu University, Gifu 501-1194, Japan. akatsuki@gifu-u.ac.jp.
Hiroyuki TomitaDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. h_tomita@gifu-u.ac.jp.
Paul G GreenDepartment of Oral and Maxillofacial Surgery, University of California at San Francisco, San Francisco, CA 94143, USA. Paul.Green@ucsf.edu.
Akira HaraDepartment of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. ahara@gifu-u.ac.jp.
Gifu University · JPGifu University of Medical Science · JPUniversity of California, San Francisco · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this review is to provide an overview of various retinal cell degeneration models in animal induced by chemicals (N-methyl-D-aspartate- and CoCl2-induced), autoimmune (experimental autoimmune encephalomyelitis), mechanical stress (optic nerve crush-induced, light-induced) and ischemia (transient retinal ischemia-induced). The target regions, pathology and proposed mechanism of each model are described in a comparative fashion. Animal models of retinal cell degeneration provide insight into the underlying mechanisms of the disease, and will facilitate the development of novel effective therapeutic drugs to treat retinal cell damage.

Indexed as

AnimalsDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalIschemiaLightOptic Nerve InjuriesRetinal DegenerationRetinal Neuronsanimal modelCoCl2EAEischemialight-inducednerve crushNMDAretinal cell degeneration

Identifiers

PMID26784179
PMCPMC4730351
OpenAlexW2235075146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.